🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Yellow Softgel Capsule(s) Serving Size
Fat/Fatty Acid Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Fat
1.5 Gram(s) (2% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 1065mg UL 3000mg

Other Ingredients

Fish Body Oil Softgel and Enteric Coating Mixed Tocopherols

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take one A.M. pack in the morning and one P.M. pack 30-60 minutes before bedtime. One softgel in the A.M. Pack

⚠️ Warnings & Precautions

Contains: Fish (Anchovy, Mackerel, Sardine, Smelt, Salmon, Tuna, Cod or a combination thereof) and Soybeans.

A.M. Pack Warning: Consult your physician prior to using this product if you are pregnant, nursing, taking, medication, or have a medical condition.

Discontinue use two weeks prior to surgery.

🧪 Formulation Notes

Contains: Fish (Anchovy, Mackerel, Sardine, Smelt, Salmon, Tuna, Cod or a combination thereof) and Soybeans.

Additional Information

A.M. Clinical Strength Omega-3

Clinical grade nutritional support for the intensely driven

CODE 210911 CSG

Product Details

DSLD Entry Date 2017-11-20
Product Type Fat/Fatty Acid
Form Softgel Capsule
Bundle Raw Elements
DSLD ID 80094
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →